Sun D, Amiri M, Meng Q, Unnithan R, French C
Cells. 2025; 14(1.
PMID: 39791705
PMC: 11719922.
DOI: 10.3390/cells14010004.
Perdaens O, van Pesch V
Int J Mol Sci. 2024; 25(23.
PMID: 39684351
PMC: 11641818.
DOI: 10.3390/ijms252312637.
Wang J, Su M, Zhang D, Zhang L, Niu C, Li C
Elife. 2024; 12.
PMID: 39642080
PMC: 11623934.
DOI: 10.7554/eLife.88319.
Blankenship H, Carter K, Pham K, Cassidy N, Markiewicz A, Thellmann M
Nat Commun. 2024; 15(1):9673.
PMID: 39516200
PMC: 11549218.
DOI: 10.1038/s41467-024-53891-1.
Geng J, Yang Y, Li B, Yu Z, Qiu S, Zhang W
Cell Rep Methods. 2024; 4(11):100898.
PMID: 39515337
PMC: 11705922.
DOI: 10.1016/j.crmeth.2024.100898.
A review of proposed mechanisms for neurodegenerative disease.
Kelser B, Teichner E, Subtirelu R, Hoss K
Front Aging Neurosci. 2024; 16:1370580.
PMID: 39439710
PMC: 11493710.
DOI: 10.3389/fnagi.2024.1370580.
Dopaminergic neuron metabolism: relevance for understanding Parkinson's disease.
Flores-Ponce X, Velasco I
Metabolomics. 2024; 20(6):116.
PMID: 39397188
PMC: 11471710.
DOI: 10.1007/s11306-024-02181-4.
The L-type calcium channel CaV1.3: A potential target for cancer therapy.
Liu X, Shen B, Zhou J, Hao J, Wang J
J Cell Mol Med. 2024; 28(19):e70123.
PMID: 39365143
PMC: 11451265.
DOI: 10.1111/jcmm.70123.
State of the Art in Sub-Phenotyping Midbrain Dopamine Neurons.
Basso V, Dobrossy M, Thompson L, Kirik D, Fuller H, Gates M
Biology (Basel). 2024; 13(9).
PMID: 39336117
PMC: 11428604.
DOI: 10.3390/biology13090690.
Calbindin and Girk2/Aldh1a1 define resilient vs vulnerable dopaminergic neurons in a primate Parkinson's disease model.
Del Rey N, Hernandez-Pinedo N, Carrillo M, Del Cerro M, Esteban-Garcia N, Trigo-Damas I
NPJ Parkinsons Dis. 2024; 10(1):165.
PMID: 39223183
PMC: 11369234.
DOI: 10.1038/s41531-024-00777-0.
Identifying potential repurposable medications for Parkinson's disease through Mendelian randomization analysis.
Wang Q, Liu F, Wang X, Zhong L, Cai B, Chen T
Sci Rep. 2024; 14(1):19670.
PMID: 39181920
PMC: 11344818.
DOI: 10.1038/s41598-024-70758-z.
Emerging perspectives on precision therapy for Parkinson's disease: multidimensional evidence leading to a new breakthrough in personalized medicine.
Wang Q, Gu X, Yang L, Jiang Y, Zhang J, He J
Front Aging Neurosci. 2024; 16:1417515.
PMID: 39026991
PMC: 11254646.
DOI: 10.3389/fnagi.2024.1417515.
The intracellular C-terminus confers compartment-specific targeting of voltage-gated calcium channels.
Chin M, Kaeser P
Cell Rep. 2024; 43(7):114428.
PMID: 38996073
PMC: 11441329.
DOI: 10.1016/j.celrep.2024.114428.
Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology.
Currim F, Tanwar R, Brown-Leung J, Paranjape N, Liu J, Sanders L
Neurotoxicology. 2024; 103:266-287.
PMID: 38964509
PMC: 11288778.
DOI: 10.1016/j.neuro.2024.06.016.
High-Resolution Proteomics Unravel a Native Functional Complex of Cav1.3, SK3, and Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels in Midbrain Dopaminergic Neurons.
Belghazi M, Iborra C, Toutendji O, Lasserre M, Debanne D, Goaillard J
Cells. 2024; 13(11.
PMID: 38891076
PMC: 11172389.
DOI: 10.3390/cells13110944.
FastBiCmrMLM: a fast and powerful compressed variance component mixed logistic model for big genomic case-control genome-wide association study.
Wang J, Chang X, Zhao Q, Zhang Y
Brief Bioinform. 2024; 25(4).
PMID: 38888457
PMC: 11184901.
DOI: 10.1093/bib/bbae290.
Potassium and calcium channels in different nerve cells act as therapeutic targets in neurological disorders.
Qiu Q, Yang M, Gong D, Liang H, Chen T
Neural Regen Res. 2024; 20(5):1258-1276.
PMID: 38845230
PMC: 11624876.
DOI: 10.4103/NRR.NRR-D-23-01766.
Calcium channel blockers and Parkinson's disease: a systematic review and meta-analysis.
Lin J, Pang D, Li C, Ou R, Yu Y, Cui Y
Ther Adv Neurol Disord. 2024; 17:17562864241252713.
PMID: 38770432
PMC: 11104025.
DOI: 10.1177/17562864241252713.
Chronic hyperactivation of midbrain dopamine neurons causes preferential dopamine neuron degeneration.
Rademacher K, Doric Z, Haddad D, Mamaligas A, Liao S, Creed R
bioRxiv. 2024; .
PMID: 38645054
PMC: 11030348.
DOI: 10.1101/2024.04.05.588321.
RNA editing of ion channels and receptors in physiology and neurological disorders.
Zhai J, Koh J, Soong T
Oxf Open Neurosci. 2024; 1:kvac010.
PMID: 38596706
PMC: 11003377.
DOI: 10.1093/oons/kvac010.